140 related articles for article (PubMed ID: 10423645)
1. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
van Wely M; Stoss M; Gorter RW
Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
3. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
4. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
Huber R; Klein R; Berg PA; Lüdtke R; Werner M
J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
[TBL] [Abstract][Full Text] [Related]
5. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
[TBL] [Abstract][Full Text] [Related]
6. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
7. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
8. Evaluating unconventional therapies.
Hajto T; Saller R
CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
[No Abstract] [Full Text] [Related]
9. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
Gorter RW; van Wely M; Stoss M; Wollina U
Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
[TBL] [Abstract][Full Text] [Related]
10. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
11. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
Stoss M; Gorter RW
Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
[TBL] [Abstract][Full Text] [Related]
12. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
[TBL] [Abstract][Full Text] [Related]
15. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R
J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study].
Huber R; Klein R; Lüdtke R; Werner M
Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):354-8. PubMed ID: 11799303
[TBL] [Abstract][Full Text] [Related]
17. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
18. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
Holtskog R; Sandvig K; Olsnes S
Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
[TBL] [Abstract][Full Text] [Related]
20. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
Kunze E; Schulz H; Gabius HJ
J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
